Business
Why the Incannex Healthcare (ASX:IHL) share price is up 15% today
The Incannex Healthcare Limited (ASX: IHL) share price has hit a 5-year high at 29 cents during early trade. The shares have since retreated back to 26 cents, up 18%.
All the excitement comes after the company released an announcement this morning pertaining to an ongoing research program.
Positive results prompting further research
Incannex Healthcare is a pharmaceutical development company utilising medicinal cannabis and psychedelics to generate treatments for a range of disorders and diseases. In today’s update, Incannex discussed the positive results of using its proprietary anti-inflammatory IHL-675A in treating inflammatory bowel disease (IBD).
The company’s IHL-675A treatment is a combination of cannabidiol ‘CBD’…
-
General10 hours agoDreams shattered as 140 Zone RV caravan customers’ worst fears realised
-
General17 hours agoTaipei metro stabbing attack leaves at least three people dead after stabbing spree
-
General9 hours agoGrace Lillian Lee weaves a path from the Torres Strait to Paris
-
Noosa News21 hours agoCollapsed Queensland caravan maker Zone RV accused of trading insolvent